Deciphering role of FGFR signalling pathway in pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Deciphering role of FGFR signalling pathway in pancreatic cancer

Published:2019-04-03 Issue:3 Volume:52 Page:e12605
ISSN:0960-7722
Container-title:Cell Proliferation
language:en
Short-container-title:Cell Prolif

Author:

Kang Xiaodiao¹,Lin Zeng¹,Xu Minhui¹,Pan Jun¹,Wang Zhi‐wei²³^ORCID

Affiliation:

1. Department of Orthopaedics Surgery The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou China

2. Center of Scientific Research The Second Affiliated Hospital of Wenzhou Medical University Wenzhou China

3. Department of Pathology, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cpr.12605

Reference145 articles.

1. Cancer statistics, 2019

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

4. Chronic Pancreatitis and Pancreatic Cancer Risk: A Systematic Review and Meta-analysis

5. Diabetes mellitus and risk of pancreatic cancer in China: a meta‐analysis based on 26 case‐control studies;Zhang JJ;Prim Care Diabetes,2018

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NF-κB Mediated Disruption of Pancreatic Signaling Pathways and its Implications for the Risk of Pancreatic Adenocarcinoma: a systematic review;2024-08-08

2. Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer;Frontiers in Oncology;2024-07-17

3. The combination of gemcitabine plus an anti-FGFR inhibitor can have a synergistic antitumor effect on FGF-activating cholangiocarcinoma;Cancer Letters;2024-07

4. Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma;Cancers;2024-04-11

5. Pancreatic cancer biomarkers: A pathway to advance in personalized treatment selection;Cancer Treatment Reviews;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3